- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr James Auran Previews Ophthalmic Trauma–Focused Content at AAO 2021
James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma, explains what he is most looking forward to at the 2021 conference of the American Academy of Ophthalmology (AAO).
The field of ophthalmic trauma began to receive more attention around 2 or 3 years ago, explained James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma. Auran will chair a session at the American Academy of Ophthalmology's 2021 conference, taking place November 12-15, on the responsibilities of the on-call ophthalmologist.
Transcript
What are you most looking forward to at the American Academy of Ophthalmology's 2021 conference?
I'm Dr Jim Auran. I'm a professor of ophthalmology at Columbia University and I've had the honor of being president of the American Society of Ophthalmic Trauma for the past 2 years. I think what I'm looking forward to most is that we have some pretty comprehensive instruction courses going, all because of the gracious efforts of the academy to allow us to do so. We have a poster session and a symposium. Trauma has been the poor stepchild of ophthalmology for a long time. There's been a tremendous amount of interest and many people have dedicated their lives to it, but they hadn't got the traction until recently. I guess it just hit a critical point about 2 to 3 years ago and here we are.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
